logo-loader

Clinigen CEO reveals more deals to come in ‘next month or so’

Last updated: 11:58 03 Mar 2015 GMT, First published: 12:58 03 Mar 2015 GMT

Peter George, chief executive of Clinigen (LON:CLIN), tells Proactive Investors about the potential deals and acquisitions that investors can expect from the specialty drug group in the near future.

George discusses why the group is challenging the safety warning that was applied to Cardioxane, as well as the healthy competition between the group’s different divisions internally.

On the interim results unveiled today, Clinigen’s CEO explains that margins were slightly lower due to increased US sales, where margins are typically lower. He expects this to return to normal in the second half.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

1 hour, 51 minutes ago